As cited by the research report titled ‘Global Infertility Treatment Market Size study, by Product (Equipment, Media & Consumables, Accessories), by Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, Other Infertility Treatment Procedures), by Patient Type (Female Infertility Treatment, Male Infertility Treatment), by End User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Research Institutes), and Regional Forecasts 2021-2027’, available with MarketStudyReport, global timber laminating adhesives market was valued at USD 1.4 billion in 2020 and is estimated to expand at a CAGR of 8.1% over 2021-2027, further reaching USD 2.4 billion in valuation by the end of study duration.
 

Declining fertility rate coupled with rising public-private investments are the major factors driving global infertility treatment market growth. Expanding medical tourism owing to availability of low treatment costs are further generating lucrative opportunities for the market development.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4339710/
 

In addition, prominent players are implementing various strategies leading to increasing adoption of infertility treatment methods, thereby positively swaying the industry dynamics. For instance, CooperSurgical collaborated with Virtus Health in 2021, to strengthen its fertility technology, which would in turn enhance the accessibility of advanced treatment methods for infertile couples.
 

Speaking of negatives, high costs associated with reproductive technologies is likely to impede the market progression over the projected timeline of 2021-2027.
 

For the record, infertility treatment includes adoption of various techniques and procedures for treating infertility which may be caused due to disorders related to maternal age, occurrence of ovulation, sextually transmitted infections, genetics, tubal occlusion or blockage, immune infertility, and others.
 

The geographical analysis of the industry extends to Asia Pacific, Europe, North America, and Latin America.
 

Experts cite that Asia Pacific is likely to emerge as a key revenue generator for the worldwide infertility treatment market over the assessment period, on account of expanding medical tourism, increasing rate of infertility, growing number of fertility centers, rising awareness regarding availability of infertility treatment procedures, increasing healthcare expenditures, and government initiatives to increase infertility treatment accessibility.
 

Leading players profiled in global infertility treatment industry are Kitazato Corporation, the Baker Company Inc., FUJIFILM Irvine Scientific Inc., IVFtech ApS, Genea Biomedx, Esco Micro Pte. Ltd., Thermo Fisher Scientific Inc., Vitrolife AB, Cook Group Inc., and the Cooper Companies Inc.